Acetyleneurea

Identification

Generic Name
Acetyleneurea
DrugBank Accession Number
DB03533
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 142.116
Monoisotopic: 142.049075456
Chemical Formula
C4H6N4O2
Synonyms
  • cis-glycoluril
  • Glycoluril
  • Glyoxaldiureine
  • Glyoxaldiurene
External IDs
  • NSC-2765

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UStreptavidinNot AvailableStreptomyces avidinii
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as imidazolines. These are organic compounds containing an imidazoline ring, which is an unsaturated ring (derived from imidazole) with two nitrogen atoms at positions 1 and 3 respectively, and containing only one CN double bond.
Kingdom
Organic compounds
Super Class
Organoheterocyclic compounds
Class
Azolines
Sub Class
Imidazolines
Direct Parent
Imidazolines
Alternative Parents
Isoureas / Propargyl-type 1,3-dipolar organic compounds / Carboximidamides / Azacyclic compounds / Organopnictogen compounds / Organooxygen compounds / Hydrocarbon derivatives
Substituents
2-imidazoline / Aliphatic heteropolycyclic compound / Azacycle / Carboximidamide / Hydrocarbon derivative / Isourea / Organic 1,3-dipolar compound / Organic nitrogen compound / Organic oxygen compound / Organonitrogen compound
Molecular Framework
Aliphatic heteropolycyclic compounds
External Descriptors
glycoluril (CHEBI:37083)
Affected organisms
Not Available

Chemical Identifiers

UNII
U9H2W4OS13
CAS number
496-46-8
InChI Key
VPVSTMAPERLKKM-XIXRPRMCSA-N
InChI
InChI=1S/C4H6N4O2/c9-3-5-1-2(7-3)8-4(10)6-1/h1-2H,(H2,5,7,9)(H2,6,8,10)/t1-,2+
IUPAC Name
(3as,6as)-octahydro-[1,3]diazolo[4,5-d]imidazole-2,5-dione
SMILES
[H][C@@]12NC(=O)N[C@]1([H])NC(=O)N2

References

Synthesis Reference

Ludwig Rottmaier, Rudolf Merten, "Glycoluril salts and a process for the preparation thereof." U.S. Patent US4433144, issued December, 1972.

US4433144
General References
Not Available
PubChem Compound
62347
PubChem Substance
46508393
ChemSpider
16743749
ChEBI
37083
PDBe Ligand
GLL
Wikipedia
Glycoluril
PDB Entries
2izk / 2rth / 2rti / 2rtj / 2rtk

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility6.2 mg/mLALOGPS
logP-2.3ALOGPS
logP-1.7Chemaxon
logS-1.4ALOGPS
pKa (Strongest Acidic)11.69Chemaxon
pKa (Strongest Basic)-3.6Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count2Chemaxon
Hydrogen Donor Count4Chemaxon
Polar Surface Area82.26 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity29.44 m3·mol-1Chemaxon
Polarizability11.82 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9644
Blood Brain Barrier+0.9884
Caco-2 permeable-0.6653
P-glycoprotein substrateNon-substrate0.6823
P-glycoprotein inhibitor INon-inhibitor0.9006
P-glycoprotein inhibitor IINon-inhibitor0.9892
Renal organic cation transporterNon-inhibitor0.9296
CYP450 2C9 substrateNon-substrate0.8026
CYP450 2D6 substrateNon-substrate0.7415
CYP450 3A4 substrateNon-substrate0.7582
CYP450 1A2 substrateNon-inhibitor0.7706
CYP450 2C9 inhibitorNon-inhibitor0.9147
CYP450 2D6 inhibitorNon-inhibitor0.9083
CYP450 2C19 inhibitorNon-inhibitor0.9204
CYP450 3A4 inhibitorNon-inhibitor0.9839
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9944
Ames testNon AMES toxic0.6262
CarcinogenicityNon-carcinogens0.945
BiodegradationNot ready biodegradable0.8015
Rat acute toxicity1.9334 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.9563
hERG inhibition (predictor II)Non-inhibitor0.9439
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0006-0900000000-4dfbb950f88d92916d72
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-1900000000-c7e79135dc787abeab1f
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0udi-2900000000-eaf8f0f0778da72ef289
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-4c962060879bf2a4145f
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-0006-9000000000-ec98b11b5536c16020e4
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-001i-9200000000-d0097df877dcb6a46924
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-130.24782
predicted
DeepCCS 1.0 (2019)
[M+H]+132.64339
predicted
DeepCCS 1.0 (2019)
[M+Na]+140.00621
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Streptomyces avidinii
Pharmacological action
Unknown
General Function
Not Available
Specific Function
The biological function of streptavidin is not known. Forms a strong non-covalent specific complex with biotin (one molecule of biotin per subunit of streptavidin).
Gene Name
Not Available
Uniprot ID
P22629
Uniprot Name
Streptavidin
Molecular Weight
18833.61 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52